RPS4Y1: A Promising Drug Target and Biomarker for Diseases (G6192)

Target Name: RPS4Y1

NCBI ID: G6192

RPS4Y1

RPS4Y1: A Promising Drug Target and Biomarker for Diseases

Ribosomal protein S4Y (RPS4Y1) is a protein that is expressed in most eukaryotic cells and plays a critical role in protein synthesis. It is a key regulator of the ribosome, which is the machine that reads the genetic code in DNA and builds proteins. Mutations in the RPS4Y1 gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, RPS4Y1 has emerged as a promising drug target and biomarker for a variety of diseases.

The RPS4Y1 gene is located on chromosome 18q21 and encodes a protein of 1,208 amino acids. It is a member of the small GTPase family 4 (GTPase-2) and is characterized by a catalytic GTPase domain and a regulatory GTPase domain. The GTPase domain is responsible for the transfer of genetic information from the RNA template to the protein, while the regulatory GTPase domain is responsible for regulating the activity of the protein.

Mutations in the RPS4Y1 gene have been linked to a variety of diseases. For example, a missense mutation has been linked to the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In addition, mutations in the RPS4Y1 gene have also been linked to the development of cancer, including breast cancer and colon cancer.

In addition to its potential as a drug target, RPS4Y1 has also been identified as a potential biomarker for a variety of diseases. For example, RPS4Y1 has been used as a biomarker for cancer, as it has been shown to be expressed in a variety of cancer types. In addition, RPS4Y1 has also been used as a biomarker for neurodegenerative diseases, as it has been shown to be expressed in the brains of individuals with neurodegenerative diseases.

Another potential application of RPS4Y1 as a drug target is its role in the regulation of cellular processes. For example, studies have shown that RPS4Y1 is involved in the regulation of cell division, as well as the regulation of the cytoskeleton. In addition, RPS4Y1 has also been shown to play a role in the regulation of protein synthesis, as it is a key regulator of the ribosome.

In conclusion, RPS4Y1 is a protein that has been linked to a variety of diseases, including cancer and neurodegenerative diseases. As a result, it has emerged as a promising drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of RPS4Y1 in these processes and to develop effective treatments for the associated diseases.

Protein Name: Ribosomal Protein S4 Y-linked 1

The "RPS4Y1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS4Y1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets